Long-term data confirmed the Zephyr Endobronchial Valve provided improvements over baseline in lung function and quality of life out to at least 24 months, and improvements in exercise capacity out to at least 18 months.
ReddyPort has launched its ReddyPort Microphone and Controller, a first-of-its-kind device that includes a single-patient use microphone for use with noninvasive ventilation interfaces.
For patients with cystic fibrosis, airway clearance physical therapy appointments have moved online and at-home lung function testing has become commonplace during the COVID-19 pandemic.
Strados Labs received FDA clearance for its Remote E-Stethoscope Platform (RESP) to measure, record, and analyze lung sounds remotely.
The US FDA has issued recommendations for healthcare providers for the potential use of ventilator splitters in situations in which no alternatives for invasive ventilatory support are available.
Extubated COVID-19 patients who began a pulmonary rehab program before day 7 post-extubation had quicker recovery than those who started later.